BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanaka Y, Yoshida K, Yamada A, Tanahashi T, Okumura N, Matsuhashi N, Yamaguchi K, Miyazaki T. Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma. Cancer Chemother Pharmacol 2016;77:1143-52. [PMID: 26896963 DOI: 10.1007/s00280-016-2985-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Tanaka Y, Takeuchi H, Nakashima Y, Nagano H, Ueno T, Tomizuka K, Morita S, Emi Y, Hamai Y, Hihara J, Saeki H, Oki E, Kunisaki C, Otsuji E, Baba H, Matsubara H, Maehara Y, Kitagawa Y, Yoshida K. Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5). ESMO Open 2021;6:100277. [PMID: 34626918 DOI: 10.1016/j.esmoop.2021.100277] [Reference Citation Analysis]
2 Imai T, Tanaka Y, Sato Y, Mase J, Suetsugu T, Fukada M, Yasufuku I, Iwata Y, Mori R, Imai H, Kato T, Okumura N, Matsuhashi N, Takahashi T, Futamura M, Yoshida K. The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis. Indian J Surg Oncol 2021;:1-9. [PMID: 34483594 DOI: 10.1007/s13193-021-01419-0] [Reference Citation Analysis]
3 Tsou YK, Liang KH, Lin WR, Chang HK, Tseng CK, Yeh CT. GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma. Oncotarget 2017;8:29151-60. [PMID: 28418863 DOI: 10.18632/oncotarget.16253] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
4 Sato Y, Tanaka Y, Imai T, Hatanaka Y, Okumura N, Matsuhashi N, Takahashi T, Yoshida K. Esophageal cancer with right vertebral artery variation observed during thoracoscopic esophagectomy: a case report. BMC Surg 2021;21:217. [PMID: 33906625 DOI: 10.1186/s12893-021-01216-0] [Reference Citation Analysis]
5 Suetsugu T, Tanaka Y, Banno S, Fukada M, Yasufuku I, Iwata Y, Imai T, Tanahashi T, Matsui S, Imai H, Matsuhashi N, Takahashi T, Yamaguchi K, Tanahashi Y, Kawada H, Matsuo M, Yoshida K. Intranodal lymphangiography for chyle leakage after esophagectomy: A case report. Mol Clin Oncol 2020;12:343-9. [PMID: 32190317 DOI: 10.3892/mco.2020.1990] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sato Y, Tanaka Y, Ohno S, Endo M, Okumura N, Matsuhashi N, Takahashi T, Saiki T, Yoshida K. Right top pulmonary vein is a venous anomaly of which surgeons should be aware in subcarinal dissection for thoracoscopic esophagectomy: a case report and literature review. World J Surg Oncol 2022;20:160. [PMID: 35590376 DOI: 10.1186/s12957-022-02635-w] [Reference Citation Analysis]
7 Yoshida K, Tanaka Y, Imai T, Sato Y, Hatanaka Y, Suetsugu T, Okumura N, Matsuhashi N, Takahashi T, Yamaguchi K. Subtotal stomach in esophageal reconstruction surgery achieves an anastomotic leakage rate of less than 1%. Ann Gastroenterol Surg 2020;4:422-32. [PMID: 32724886 DOI: 10.1002/ags3.12336] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Cai J, Zhou S, Luo Y, Liu A. Effect and safety of anlotinib combined with S-1 for recurrent or metastatic esophageal cancer patients who refused or were intolerant to intravenous chemotherapy. Medicine (Baltimore) 2021;100:e28126. [PMID: 34941058 DOI: 10.1097/MD.0000000000028126] [Reference Citation Analysis]
9 Tanaka Y, Yoshida K, Suetsugu T, Imai T, Matsuhashi N, Yamaguchi K. Recent advancements in esophageal cancer treatment in Japan. Ann Gastroenterol Surg 2018;2:253-65. [PMID: 30003188 DOI: 10.1002/ags3.12174] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
10 Sato Y, Sugimoto M, Tanaka Y, Suetsugu T, Imai T, Hatanaka Y, Matsuhashi N, Takahashi T, Yamaguchi K, Yoshida K. Holographic image-guided thoracoscopic surgery: possibility of usefulness for esophageal cancer patients with abnormal artery. Esophagus 2020;17:508-11. [PMID: 32246296 DOI: 10.1007/s10388-020-00737-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Suetsugu T, Tanaka Y, Sato Y, Fukada M, Yasufuku I, Yoshida K. Intraperitoneal perforation through lymph node metastases in a patient with esophageal squamous cell carcinoma during intensive chemotherapy: A case report with literature review. Int J Surg Case Rep 2022;93:106944. [PMID: 35334369 DOI: 10.1016/j.ijscr.2022.106944] [Reference Citation Analysis]
12 Tanaka Y, Ueno T, Yoshida N, Akutsu Y, Takeuchi H, Baba H, Matsubara H, Kitagawa Y, Yoshida K. The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study). Esophagus 2018;15:239-48. [PMID: 30225745 DOI: 10.1007/s10388-018-0620-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Akiyama Y, Sasaki A, Endo F, Nikai H, Amano S, Umemura A, Baba S, Chiba T, Kimura T, Takahara T, Nitta H, Otsuka K, Mizuno M, Kimura Y, Koeda K, Iwaya T. Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis. World J Surg Oncol 2018;16:122. [PMID: 29966526 DOI: 10.1186/s12957-018-1420-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
14 Niu F, Liu Y, Jing Z, Han G, Sun L, Yan L, Zhou L, Wu Y, Xu Y, Hu L, Zhao X. Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma. Cancer Lett 2018;420:60-71. [PMID: 29408653 DOI: 10.1016/j.canlet.2018.01.066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
15 Zhao Q, Zhu X, Ke JM, Su XY, Yi J, Wu DL, Lin J, Deng ZQ. Circular RNA BMI1 Serves as a Potential Target for Diagnosis and Treatment in Esophageal Cancer. Technol Cancer Res Treat 2021;20:15330338211033075. [PMID: 34278876 DOI: 10.1177/15330338211033075] [Reference Citation Analysis]
16 Imai T, Tanaka Y, Ojio H, Sato Y, Suetsugu T, Fukada M, Yasufuku I, Iwata Y, Imai H, Okumura N, Matsuhashi N, Takahashi T, Noguchi K, Miyazaki T, Yoshida K. Successful treatment of cervical and upper thoracic esophageal adenocarcinoma using induction chemotherapy followed by surgery: a case report. Int Cancer Conf J 2021;10:334-40. [PMID: 34567948 DOI: 10.1007/s13691-021-00505-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sato Y, Tanaka Y, Suetsugu T, Takaha R, Ojio H, Hatanaka Y, Imai T, Okumura N, Matsuhashi N, Takahashi T, Kato H, Yoshida K. Three-step operation for esophago-left bronchial fistula with respiratory failure after esophagectomy: a case report with literature review. BMC Gastroenterol 2021;21:467. [PMID: 34906075 DOI: 10.1186/s12876-021-02051-6] [Reference Citation Analysis]